Lakshminarayanan, Vani <br/><br/>
MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.  [electronic resource] 

 -  PloS one  2016 
 - e0145920 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0145920  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens--chemistry<br/>Cancer Vaccines--chemistry<br/>Cell Line, Tumor<br/>Glycosylation<br/>Humans<br/>Mice<br/>Mice, Transgenic<br/>Mucin-1--genetics<br/>Neoplasms, Experimental--immunology<br/>Peptides--chemistry<br/>T-Lymphocytes--immunology<br/>Tumor Escape